WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005112637) FORMULATIONS FOR NON-PARENTERAL USE INCLUDING HYDROPHOBIC CYCLODEXTRINS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/112637    International Application No.:    PCT/US2005/016659
Publication Date: 01.12.2005 International Filing Date: 12.05.2005
Chapter 2 Demand Filed:    13.12.2005    
IPC:
A01N 43/04 (2006.01), A61K 31/75 (2006.01)
Applicants: DECODE CHEMISTRY, INC. [US/US]; 2501 Davey Road, Woodridge, IL 60517 (US) (For All Designated States Except US).
THORSTEINSSON, Thorsteinn [IS/US]; (US).
DUAN, Matthew [US/US]; (US).
O'FEE, Robert, P. [US/US]; (US)
Inventors: THORSTEINSSON, Thorsteinn; (US).
DUAN, Matthew; (US).
O'FEE, Robert, P.; (US)
Agent: HOSTER, Jeffrey, M.; Jeffrey M. Hoster, LTD, 13 Woodland Drive, Lemont, IL 60439 (US)
Priority Data:
60/571,253 14.05.2004 US
Title (EN) FORMULATIONS FOR NON-PARENTERAL USE INCLUDING HYDROPHOBIC CYCLODEXTRINS
(FR) PRÉPARATIONS À USAGE NON PARENTÉRAL COMPRENANT DES CYCLODEXTRINES HYDROPHOBES
Abstract: front page image
(EN)A novel system for non-parenteral formulations comprising cyclodextrins is disclosed. The system includes hydrophobic cyclodextrins and amino acids and homo- or co- polymers thereof. The cyclodextrins and amino acids form a complex with pharmaceutical and other ingredients to achieve greatly improved solubility and/or enhance stability. The complexes can be used for delivery to mammals in a wide variety of non-parenteral formulations.
(FR)Est dévoilé un nouveau système pour des préparations à usage non parentéral comprenant des cyclodextrines. Le système comprend des cyclodextrines hydrophobes et des acides aminés et leurs homo- ou co- polymères. Les cyclodextrines et les acides amniés forment un complexe avec d’autres ingrédients, notamment pharmaceutiques, pour obtenir une bien meilleure solubilité et/ou une plus grande stabilité. Les complexes peuvent être administrés à des mammifères dans un grand nombre de préparations non parentérales différentes.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)